Home

Aarey Drugs & Pharmaceuticals Ltd PE Ratio

Image

Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS

PE

23.3

Last updated on: Jan 12, 2025

Key Highlights

  • The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd is 23.3 as of 12 Jan 13:45 PM .
  • The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 5.4 on March 2020 to 26.8 on March 2024 . This represents a CAGR of 37.77% over 5 years.
  • The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 57.45 as of 10 Jan 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd

No data available

Company Fundamentals for Aarey Drugs & Pharmaceuticals Ltd

Image

Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS

Share Price

₹ 57.45

-0.85 (-1.46%)

stock direction

Last updated on: Jan 10, 2025

Market Price of Aarey Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Aarey Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
10 Jan 202557.45
08 Jan 202558.3
07 Jan 202558.37
06 Jan 202558.41
03 Jan 202557.84
01 Jan 202556.71
31 Dec 202456.71
30 Dec 202455.6
27 Dec 202455.71
26 Dec 202455.71

SWOT Analysis Of Aarey Drugs & Pharmaceuticals Ltd

Strength

0

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Aarey Drugs & Pharmaceuticals Ltd

Asset Value vs Market Value of Aarey Drugs & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Aarey Drugs & Pharmaceuticals Ltd160.6
Sun Pharmaceuticals Industries Ltd428533
Divis Laboratories Ltd153076
Cipla Ltd118723
Dr Reddys Laboratories Ltd112998

PE Ratio of Aarey Drugs & Pharmaceuticals Ltd Explained

``

160.6

Market cap

6

Earnings

23.3X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Aarey Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Aarey Drugs & Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd

No data available

* All values are in %

About Aarey Drugs & Pharmaceuticals Ltd

  • Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
  • In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company.
  • Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
  • The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.

Aarey Drugs & Pharmaceuticals Ltd News Hub

Aarey Drugs & Pharmaceuticals standalone net profit rises 72.22% in the June 2024 quarter

Net profit of Aarey Drugs & Pharmaceuticals rose 72.22% to Rs 1.24 crore in the quarter ended June 2

Read more

2024-08-16 00:00:00

Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 Aug

Read more

2024-08-10 00:00:00

Aarey Drugs & Pharmaceuticals schedules AGM

Aarey Drugs & Pharmaceuticals announced that the 34th Annual General Meeting (AGM) of the company wi

Read more

2024-09-19 00:00:00

Aarey Drugs & Pharmaceuticals to conduct board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1 Octo

Read more

2024-09-25 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Aarey Drugs & Pharmaceuticals Ltd

What is the current PE Ratio of Aarey Drugs & Pharmaceuticals Ltd?

The Current PE Ratio of Aarey Drugs & Pharmaceuticals Ltd is 23.26 as on 12 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Jan 2025.

What was the PE Ratio of Aarey Drugs & Pharmaceuticals Ltd last year?

The PE Ratio of Aarey Drugs & Pharmaceuticals Ltd was 15.89 last year, now the PE ratio is 23.26, showing a year-on-year growth of 46.4%.

What does the PE Ratio of Aarey Drugs & Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Aarey Drugs & Pharmaceuticals Ltd is 23.26. This ratio indicates that investors are willing to pay 23.26 times the earnings per share for each share of Aarey Drugs & Pharmaceuticals Ltd.

What is the PE Ratio Growth of Aarey Drugs & Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Aarey Drugs & Pharmaceuticals Ltd grew by 46.4% whereas, the EPS ratio grew by 29.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions